Table 2.
Characteristics of study cohort (N =149) versus those who were excluded (N = 195)
| Characteristics | Total n (%) | Excluded n (%) | Study Cohort n (%) | P value | |
|---|---|---|---|---|---|
| Gender | Male | 216 (63) | 132 (68) | 84 (56) | 0.0332• |
| Female | 128 (37) | 63 (32) | 65 (44) | ||
| Race | White | 213 (62) | 121 (62) | 92 (62) | 0.8501 |
| Black | 68 (20) | 40 (21) | 28 (19) | ||
| Other | 63 (18) | 34 (17) | 29 (20) | ||
| Diagnosis | Non-malignant | 68 (20) | 35 (18) | 33 (22) | 0.3422 |
| Malignant | 276 (80) | 160 (82) | 116 (79) | ||
| Primary Disease | Others | 212 (62) | 125 (64) | 87 (58) | 0.3143 |
| Lymphoid Malignancies + Aplastic Anemia | 132 (38) | 70 (36) | 62 (42) | ||
| Age at alloHCT | Age at alloHCT <10 | 174 (52) | 109 (56) | 65 (44) | 0.0294• |
| Age at alloHCT >=10 | 170 (49) | 86 (44) | 84 (56) | ||
| Donor Type | Unrelated | 113 (33) | 56 (29) | 57 (38) | 0.0650 |
| Related | 231 (67) | 139 (71) | 92 (62) | ||
| Conditioning regimen | Total Body Radiation | 204 (59) | 103 (54) | 101 (68) | 0.0103• |
| No TBI | 137 (40) | 89 (46) | 48 (32) | ||
•
Values depicted in bold were statistically significant
Abbreviations: alloHCT, allogeneic hematopoietic stem cell transplantation; TBI, Total body irradiation